Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Guided SAPB for Rib Fractures
NCT05748366Recruiting
- Sponsor
- WellSpan Health
- Start
- Mar 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in rib fracture (2 arms), sponsored by WellSpan Health. Primary endpoint: Visual Analog Pain Score at 2 hours. Started Mar 2023; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT05748366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05748366.